In Brief This Week: South Korea; Cancer Genetics; Danaher; Abbott; Health Discovery; Biocept | GenomeWeb

NEW YORK (GenomeWeb News) – The South Korean government this week announced the launch of a post-genome project aimed at developing and commercializing new genomic technologies.

South Korea's Yonhap News Agency reported that the South Korean government plans to spend KRW578 billion ($539 million) during the next eight years on the effort, starting with KRW45.5 billion in 2014.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: statistical approach to examine intra-tumor heterogeneity, new genetic condition called otulipenia, and more.

Blood tests looking for biomarker changes could catch mental illnesses earlier, Newsweek reports.

DNA testing offers Korean adoptees a way to find their birth parents that sidesteps bureaucratic red tape, according to the New York Times.

A National Institutes of Health researcher has filed an Equal Employment Opportunity complaint against the agency, the Washington Post reports.